Donald Trump gave Tiger Woods his stamp of approval after the golf champion announced his new relationship with Vanessa Trump, ex-wife of Donald Trump Jr. Val Kilmer, who died April 1 at age 65, ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial comparing a high dose of Ocrevus® (ocrelizumab) intravenous (IV) infusion to the ...
Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...
Biosimilar challenges include complex manufacturing processes and regulatory obstacles, offset by less regulated market ...
C, shares how she saved Dr Jacquelyn Lacera’s life from a near-fatal cardiovascular event while aboard a flight from Hawaii.
Red light therapy (LLLT) may boost muscle recovery, reduce soreness, and improve performance — here’s what experts at Next ...
Organon’s workforce cuts come several months after the company’s loss of exclusivity to its second-largest product, Atozet.
Sitting around a wrestling ring, churchgoers roared as local hero Billy O’Keeffe body-slammed a fighter named Disciple.
Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy and safety profile with IV pembrolizumab.
Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today revealed that Marketing Maven is No. 124 on its fifth annual Inc. Regionals: Pacific ...
2d
Investor's Business Daily on MSNIBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival RocheTG Therapeutics rallied Wednesday after Roche's rival multiple sclerosis treatment, Ocrevus, missed its mark in a study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results